Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-04-22 @ 4:47 AM
Study NCT ID:
NCT02392559
Status:
COMPLETED
Last Update Posted:
2022-11-08
First Post:
2015-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-25
First Submit QC Date:
None
Study First Post Date:
2015-03-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-09
Results First Submit QC Date:
None
Results First Post Date:
2020-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-04
Last Update Post Date:
2022-11-08
Last Update Post Date Type:
ACTUAL